Veuillez indiquer si vous voulez ou non que les autres utilisateurs puissent voir dans votre profil que cette bibliothèque est l’une de vos préférées.
Trouver un exemplaire dans la bibliothèque
Recherche de bibliothèques qui possèdent cet ouvrage...
Détails
| Type d’ouvrage : | Ressource Internet |
|---|---|
| Type de document : | Livre, Ressource Internet |
| Tous les auteurs / collaborateurs : |
Karen F Greif; Jon F Merz |
| ISBN : | 9780262072809 0262072807 9780262572392 0262572397 |
| Numéro OCLC : | 71266357 |
| Description : | xii, 385 p. ; 24 cm. |
| Contenu : | 1. An uneasy balance : science advising and the politicization of science -- 2. Big science : the Human Genome Project and the public funding of science. Funding biomedical research : peer review versus pork barrel ; Choosing research directions : advocacy, the "disease--of-the-month," and Congressional oversight -- 3. Who owns the genome? The patenting of human genes. Who owns life? Mr. Moore's spleen ; The Canavan disease patent case -- 4. Manufacturing children : assisted reproductive technologies and self-regulation by scientists and clinicians. Brave new world revisited : human cloning and stem cells ; The Asilomar Conference on Recombinant DNA : a model for self-regulation? -- 5. Protecting the public : the FDA and new AIDS drugs. Seminal events : the evolution of regulations for research ; Placebo controls in clinical research -- 6. Cosmetic science : breast implants and the courts. Setting limits on expert testimony : Bendectin and birth defects ; DNA forensics in criminal trials : how new science becomes admissible -- 7. Selling science : new cancer treatments and the media. Responsible journalism : are there health risks from electromagnetic fields? -- 8. Concealing evidence : science, big business, and the tobacco industry. The academic-industrial complex and conflict of interest ; The darker side of science : scientific misconduct -- 9. Science in the national interest : bioterrorism and civil liberties. Emerging diseases : SARS and government responses ; Limiting research in an age of bioterrorism -- 10. Science misunderstood : genetically modified organisms and international trade. mad cow disease, international trade and the loss of public trust -- 11. Dangers in the environment : air pollution policy. Environmental poisoning : mitigating lead exposure ; Can we ever be safe? Risk and risk assessment -- 12. Who lives and who dies? Organ transplantation. Animals as organ factories : xenotransplantation ; Is there a right to die? -- 13. Concluding remarks : the challenges of science policy. |
| Titre de collection : | Basic bioethics |
| Responsabilité : | Karen F. Greif and Jon F. Merz. |
| Plus d’informations : |
Critiques
Ajoutez une critique et partagez vos impressions avec d’autres lecteurs.
Soyez le premier.
Ajoutez une critique et partagez vos impressions avec d’autres lecteurs.
Soyez le premier.
Tags
Ajoutez des tags pour "Current controversies in the biological sciences : case studies of policy challenges from new technologies".
Soyez le premier.
